![]() |
|
|
Vol. 280, Issue 1, 255-260, 1997
Cardiovascular Pharmacology, Pharmacia & Upjohn, Inc., Kalamazoo,
Michigan
A high-affinity receptor site for 3H-P1075 previously
observed in rat aorta has been proposed to mediate the vasorelaxation effects of P1075 and other ATP-sensitive K+ channel
(KATP) openers. We tested this hypothesis by correlating the receptor binding of 3H-P1075 with its vasorelaxation
effects in several isolated vascular preparations from three species:
rat, rabbit and dog. In rat aorta and mesenteric artery,
3H-P1075 (1-5 nM) showed high amounts of specific binding
(5-10 fmol/mg tissue), which was 48 to 79% of total binding. In
contrast, little (
17%) to no specific binding of
3H-P1075 (1-5 nM) was observed in dog coronary artery, dog
mesenteric artery or rabbit mesenteric artery. However, all vascular
preparations studied relaxed with P1075 (1-100 nM), showing maximal
relaxations at 30 to 100 nM. The P1075 relaxation EC50
values in rat aorta, rabbit mesenteric artery and dog coronary artery
ranged from 7.5 to 24.1 nM depending on the level of contractile
activation. Thus, the pharmacological effect of P1075 could be
correlated with the presence of specific receptor binding sites only in
rat vascular preparations. These data show that there are significant
differences in the characteristics of the proposed specific receptor
site for 3H-P1075 in different vascular preparations from
different species, and they raise questions regarding the
pharmacological significance of this KATP opener binding
site. Until such questions are resolved, it appears that the study of
functional significance of this receptor site as well as further
biochemical characterization of this receptor site may necessitate the
use of only the rat vascular preparations.
This article has been cited by other articles:
![]() |
R. CAO, B. T. HIGASHIKUBO, J. CARDIN, U. KNOBLICH, R. RAMOS, M. T. NELSON, C. I MOORE, and J. C. BRUMBERG Pinacidil induces vascular dilation and hyperemia in vivo and does not impact biophysical properties of neurons and astrocytes in vitro Cleveland Clinic Journal of Medicine, April 1, 2009; 76(Suppl_2): S80 - S85. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Khan, N. R. Higdon, J. B. Hester, and K. D. Meisheri Pharmacological Characterization of Novel Cyanoguanidines as Vascular KATP Channel Blockers J. Pharmacol. Exp. Ther., December 1, 1997; 283(3): 1207 - 1213. [Abstract] [Full Text] |
||||